Japanese
English
- 有料閲覧
- Abstract 文献概要
- 1ページ目 Look Inside
抄録 電顕酵素抗体法を用いて,脳腫瘍血管,非腫瘍脳組織における第8因子関連抗原(F VIII R:Agと略す)の微細局在について報告した。①F VIII R:Agの分布は,腫瘍細胞には全く認めず,微小血管とくにendothelial proliferation,あるいはhyperplasiaのみられるものに著明で,血管径が大きくなるに従ってその染色性の分布がせまく,弱まる傾向であった。②免疫電顕法では,悪性,良性ともに血管内皮細胞に陽性で,pericyteには認めず,その他基底膜,血管内腔および血管内腔側内皮細胞膜面に認めた。血管内皮細胞では,endoplasmic reticulum (E.R.),vacuole,vesicle perinuclear spaceに認められた。③悪性腫瘍では,内皮細胞内のF VIII R:Agの分布が良性および非腫瘍脳組織に比較し多く,とくに内皮細胞内E.R.に著明に陽性であることが特徴で,悪性腫瘍血管内皮細胞におけるF VIII R:Agの産生亢進が示唆された。
Using both immunohistochemical and immuno-electron microscopic techniques with periodate-lysine-paraformaldehyde (PLP) fixation, we have studied the distribution of Factor VIII-related antigen (F VIII R : Ag) in 14 cases of human cent-ral nervous system (CNS) tumors and 1 sample of non-tumor brain tissue. F VIII R : Ag was localized to the vascular lumen, to the intercellular spaces between endothelial cells (apparently without tight junctions), and to the endothelial cell basement membrane. In the cytoplasm, F VIII R : Ag was found in the endoplasmic reticulum, perinuclear space, and intracytoplasmic vacuoles and vesiclesonly. Characteristic of malignant tumors (6 out of 7) was strongly-positive dilated endoplasmic reti-culum, whereas only 1 of 5 benign tumors showed such staining. This appears to reflect increased F Vlll R : Ag synthesis in the malignant vessels. The non-tumor brain tissue showed normal capil-lary structure and very little F VIII R : Ag im-munoreactivity. Six of 12 tumors and the non-tumor brain showed perinuclear F VIII R : Ag. Although the basement membranes were more irregular in the malignant tumors, staining was not grossly different from that of the more benign lesions. The finding of both ad-and ablumial vesicles containing F VIII R : Ag suggests that endocytosis, transcellular transport, and/or exo-cytosis, as well as F VIII R : Ag synthesis, occurs in the tumor endothelial cells. The relationship of these F VIII R : Ag abnormalities to the hyper-coagulable state seen in some malignant brain tumor patients remains to be clarified.
Copyright © 1984, Igaku-Shoin Ltd. All rights reserved.